CRP and hyperlipidemia: Finally, we did not have data on the treatment or control of diabetes, the presence of other diabetic microvascular complications that may increase LEA risk, or the presence of potential confounders such as hyperlipidemia, C-reactive protein and homocysteine levels [36].